SCHEMBL7255706

SCHEMBL7255706

Clc1ccnc2ccsc12.Clc1ncnc2ccsc12

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 1/20 0.77
MKNK1 Q9BUB5 1/20 0.77
MKNK2 Q9HBH9 1/20 0.77
FADS1 O60427 1/20 0.40
ADORA2A P29274 4/20 0.40
ADORA1 P30542 3/20 0.40
HTR2C P28335 1/20 0.38
PDE4A P27815 2/20 0.37
PDE4B Q07343 2/20 0.37
PDE4C Q08493 2/20 0.37
PDE4D Q08499 2/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
EGFR P00533 2/20 0.35
ADORA2B P29275 1/20 0.35
PDPK1 O15530 1/20 0.34
PARP1 P09874 1/20 0.34
PIP4K2C Q8TBX8 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
TEK Q02763 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL104668 0.88 AXL (0.53) AXLMKNK1MKNK2FADS1ADORA2A
SCHEMBL29365402 0.88 AXL (0.53) AXLMKNK1MKNK2FADS1ADORA2A
SCHEMBL659673 0.88 AXL (1.00) AXLMKNK1MKNK2FADS1ADORA2A
SCHEMBL29991404 0.88 AXL (1.00) AXLMKNK1MKNK2FADS1ADORA2A
SCHEMBL660369 0.65 AXL (0.48) AXLMKNK1MKNK2ADORA2AADORA1
SCHEMBL4037241 0.65 AXL (0.44) AXLMKNK1MKNK2ADORA2AADORA1
SCHEMBL29631094 0.65 AXL (0.44) AXLMKNK1MKNK2ADORA2AADORA1
SCHEMBL21393430 0.65 AXL (0.44) AXLMKNK1MKNK2ADORA2AADORA1
SCHEMBL29377266 0.65 AXL (0.48) AXLMKNK1MKNK2ADORA2AADORA1
SCHEMBL29368189 0.65 AXL (0.44) AXLMKNK1MKNK2ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003000194-A2 THIENOPYRIDINE AND THIENOPYRIMIDINE ANTICANCER AGENTS PFIZER INC. (US) 2003-01-03 WO disclosed